In vitro anticoagulant and antioxidant activities of Jatropha gossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical applications
© Félix-Silva et al.; licensee BioMed Central Ltd. 2014
Received: 14 May 2014
Accepted: 6 October 2014
Published: 20 October 2014
Jatropha gossypiifolia L. (Euphorbiaceae) is a medicinal plant largely used in folk medicine. Teas from the leaves are popularly used as an antithrombotic agent and the branches are frequently employed as a "thick blood" agent. Considering that the anticoagulant activity associated with antioxidant properties could be beneficial for various cardiovascular diseases, this study’s aim is the evaluation of anticoagulant and antioxidant activities of J. gossypiifolia leaves, seeking new therapeutic purposes for this plant.
The aqueous leaf crude extract (CE) was prepared by decoction and was fractionated by liquid-liquid partition with solvents of increasing polarity. The phytochemical analysis was performed by thin layer chromatography (TLC) and by the spectrophotometric quantification of sugars, proteins and phenolic compounds. The anticoagulant activity was evaluated by prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. The capacity to act in the fibrinolytic system (fibrinolytic and fibrinogenolytic activities) was also assessed. The antioxidant activity was evaluated by total antioxidant capacity, reducing power, copper chelating activity, iron chelating activity, hydroxyl radical scavenging activity and superoxide radical scavenging assays. The potential toxicity was evaluated using hemolytic assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay on HEK-293 cells.
CE showed significant anticoagulant activity in aPTT test, while no action was observed in PT test, suggesting a preferential action toward the intrinsic and/or common pathway of coagulation. No effect was observed in the fibrinolytic system. Using the aPTT test, it was observed that the residual aqueous (RA) fraction was the most active, being two times more active than CE. RA presented very significant antioxidant activity in all models tested comparable to or even higher than CE. Regarding the safety, CE and RA did not produce significant cytotoxicity in both tests employed. Phytochemical analysis revealed the presence of alkaloids, flavonoids, proteins, tannins, steroids and/or terpenoids and sugars.
CE and RA possessed significant anticoagulant and antioxidant activity and absence of cytotoxic effect in vitro, thus showing the potential of the plant, especially RA fraction, as a new source of bioactive molecules for therapeutic purposes, with particular emphasis on the treatment of cardiovascular diseases.
KeywordsJatropha gossypiifolia Euphorbiaceae "Pinhão-roxo" "Bellyache bush" Anticoagulant Antioxidant Cytotoxicity Fibrinolytic Thin layer chromatography
The use of plants with medicinal purposes for the prevention and/or treatment of diseases is one of the most ancient forms of primary health care[1, 2]. Plants produce several secondary metabolites that present many important biological activities. Anticoagulant and antioxidant activities could be highlighted amongst these.
Anticoagulant drugs are needed for the short-term treatment of arterial and venous thrombotic disorders and for the long-term prevention of recurrences. Although heparin has been the mainstay of anticoagulant treatment for acute thrombotic disorders for decades, this drug presents some limitations related to its clinical application, such as inefficacy in antithrombin deficient patients, bleeding complications, potential for the development of heparin-induced thrombocytopenia, immunosuppression and osteoporotic effect with long-term application as side effects[3, 4]. So, the search for new substances with anticoagulant and antithrombotic activities is relevant. Medicinal plants have historically been the first source of anticoagulant and antithrombotic molecules.
Reactive oxygen species (ROS) are free radicals naturally produced in the cells and are involved in many cellular biochemical activities such as signal transduction, gene transcription and regulation of soluble guanylate cyclase activity[6, 7]. However, overproduction of free radicals or failure in endogenous antioxidant mechanisms can cause oxidative damage to biomolecules (lipids, proteins and DNA), eventually leading to many chronic diseases, such as atherosclerosis, cardiovascular diseases, cancer, diabetes, rheumatoid arthritis, post-ischemic perfusion injury, myocardial infarction, chronic inflammation, stroke, septic shock, aging and other degenerative diseases in humans[6, 7]. Antioxidants are important substances that have the ability to protect the organism from the damage caused by the oxidative stress. Due to this ability, there is a special interest in the presence of natural antioxidants in medicinal plants that may help the organism to maintain the normal balance of ROS[7, 8]. Plants are frequently reported as a good source of antioxidant components, such as phenolic compounds.
Atherosclerosis is a vascular disease characterized by the accumulation of fatty substances, cholesterol, cellular waste products, calcium and other substances in the arterial wall, and involves an inflammatory response to the local low-density lipoprotein (LDL)[9, 10]. The oxidation of LDL is a well-described phenomenon in atherosclerosis, and ROS are involved in the pathophysiology of this disease. Among the injuries that may occur during atherosclerosis progression, the most severe consequence is the promotion of thrombous formation, generated by the activation of platelet aggregation and blood coagulation. Thus, compounds with anticoagulant and antioxidant can be used in the actual medicine for treatment of atherosclerosis.
Jatropha gossypiifolia L. is a medicinal plant belonging to the Euphorbiaceae family, popularly known in Brazil as "pinhão-roxo" or known worldwide as "bellyache-bush". This species is widely distributed in countries of tropical, subtropical and dry tropical weather and tropical semi-arid regions of Africa and Americas. Several human and veterinary uses in traditional medicine are described for different parts (leaves, stems, roots, seeds and latex). Preparations based on this plant, such as infusion, decoction and maceration, by oral or topical routes, are frequently used. The most frequent reports relate to its antihypertensive, anti-inflammatory, antiophidic, analgesic, antipyretic, antimicrobial, healing, haemostatic, anti-anemic and antidiabetic applications, among other examples[13–15]. An important feature of J. gossypiifolia species is that, due to its important potential medicinal applications, it is included in the National List of Medicinal Plants of Interest to Brazilian Public Health System (Relação Nacional de Plantas Medicinais de Interesse ao Sistema Único de Saúde Brasileiro – RENISUS), which is a report published by the Brazilian Health Ministry that includes 71 species of medicinal plants that have the potential to generate pharmaceutical products of interest to public health.
Regarding the chemical compounds ascribed to this species, alkaloids, coumarins, flavonoids, lignoids, phenols, saponnins, steroids, tannins and terpenoids were already detected in different extracts from different parts of this plant. Among the main activities already studied for this species (including many kinds of extracts from different parts of the plant), the antihypertensive, antineoplasic, antimicrobial, antiophidic and anti-inflammatory activities mainly stand out, supporting some of its popular uses[15, 18, 19].
The present study was carried out aiming to evaluate the anticoagulant and antioxidant activities of the aqueous leaf extract of J. gossypiifolia. Using a bioguided fractionation, the main fraction responsible for the anticoagulant activity was identified (residual aqueous fraction). This fraction also possessed significant antioxidant activity in vitro and absence of cytotoxic effect in vitro, thus showing the potential of the plant and, more specifically, of this fraction as a new source of bioactive molecules for therapeutic purposes, with particular emphasis on the treatment of cardiovascular diseases such as atherosclerosis, since anticoagulants and antioxidants are used in the treatment of these disorders.
Chemicals and reagents
Luteolin, orientin, isoorientin, vitexin, isovitexin, D-glicose, gallic acid, Cremophor® EL (polyoxyl 35 castor oil), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), Bothrops jararaca snake venom, bovine fibrinogen, bovine serum albumin, ascorbic acid, pyrocatechol violet and ferrozine were purchased from Sigma-Aldrich (St. Louis, MO, USA). All reagents of sodium dodecilsuphate polyacrylamide gel electrophoresis were purchased from GE Healthcare (Piscataway, NJ, USA). All reagents used for cell culture procedures were purchased from Cultilab (Campinas, SP, Brazil). All other reagents and solvents used were of analytical grade. The water used was purified by reverse osmosis.
Preparation of pool of plasma and red blood cell (RBC) suspension
After written informed consent has been obtained, blood from adult healthy volunteers free from medication for at least two weeks and fasted for at least 8 h was taken by venipuncture and collected into 0.105 M sodium citrate (9:1 v/v, blood: anticoagulant) and K3EDTA (1,5 mg EDTA: 1 mL blood) tubes (BD Vacutainer®, Franklin Lakes, NJ, USA). The human plasma pool was prepared from the supernatants obtained after centrifugation at 800 g for 10 min at room temperature of the citrated blood. The plasma was used up to two weeks after being obtained. For red blood cell (RBC) suspension preparation, blood collected with EDTA was centrifuged at 560 g for 10 min at room temperature and the red blood cell pellet was subsequently rinsed three times with PBS. A 20% (v/v) RBC suspension was obtained by dilution with PBS. The RBC was used immediately after preparation. The procedures for human blood collection were approved by the Ethics Committee in Human Research from Federal University of Rio Grande do Norte (protocol no. 092/09).
Leaves of Jatropha gossypiifolia L. (Euphorbiaceae) were collected in Carnaubais, municipality of Rio Grande do Norte State, Brazil, at coordinates 36.80°W 5.27°S, in April 2012. The botanical identification of the material was performed by Msc. Alan de Araújo Roque and a voucher specimen was deposited at the Herbarium from the Centro de Biociências of Universidade Federal do Rio Grande do Norte, Brazil (UFRN 12561). The collection of the plant material was conducted under authorization of Brazilian Authorization and Biodiversity Information System (SISBIO) (process number 35017) and Brazilian Access Authorization and Dispatch Component of Genetic Patrimony (CGEN) (Process 010844/2013-9). The leaves were dried at room temperature for about 18 days, triturated with an industrial blender and stored in hermetically sealed bottles away from light and humidity until use for extract preparation.
Dried leaves were submitted to decoction (1:10 w/v, plant: solvent) for 15 min at a temperature of around 100°C to obtain the aqueous leaf extract of J. gossypiifolia, named crude extract (CE). CE, obtained after vacuum filtration, was freeze-dried and one part of it was dissolved in PBS at adequate concentrations for the biological assays.
Crude extract (CE) fractionation
CE was fractionated by liquid-liquid partition with solvents of crescent polarity in order to obtain the dichloromethane (CH2Cl2), ethyl acetate (AcOEt), n-buthanol (BuOH) and residual aqueous (RA) fractions. The fractions were dried and one part of them was dissolved in PBS or in Cremophor® 5% solution in PBS (according to fraction solubility), at adequate concentrations for the biological assays.
For phytochemical characterization of CE and fractions, they were submitted to thin layer chromatography (TLC) analysis and had the content of sugar, protein and phenolic compounds determined spectrophotometrically.
Thin Layer Chromatography (TLC)
CE and fractions were analyzed by TLC using aluminium pre-coated sheets with silica gel F254 (Merck®, Darmstadt, Germany) as adsorbent. Three mobile phases were employed: (1) ethyl acetate: formic acid: water (8:1:1 v/v/v), (2) toluene: ethyl acetate: formic acid (5:5:0.5 v/v/v) and (3) n-butanol: acetic acid: water (3:1:1 v/v/v). The chromatograms were analyzed under 254 and 365 nm UV light and different spray reagents were used according to the metabolite investigated (sulfuric vanillin + heating, natural product reagent + UV 365 nm, ferric chloride, Dragendorff reagent and ninhindrin + heating). The retention factors (Rf), color and behavior of the spots were recorded for further comparison with chromatographic profiles of reference substances from the literature in the area. Standard samples of flavonoids were employed for co-TLC analysis.
Total content of sugars, proteins and phenolic compounds
Total sugar was estimated by Dubois method using D-glicose as standard. Phenolic compounds were determined by Folin-Ciocalteu’s method using gallic acid as standard. The Bradford method was used for protein quantification using bovine serum albumin (BSA) as standard.
Coagulation and fibrinolysis assays
The action of CE and fractions on haemostatic system was assessed by the evaluation of its anticoagulant activity in prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests, as well as by its capacity to act in fibrinolytic system.
Prothrombin Time (PT) test
The action in extrinsic pathway was evaluated by PT test, as previously described in literature, with a few modifications. The test was carried out using commercial reagent kits (CLOT Bios Diagnostica, São Paulo, SP, Brazil). Plasma (90 μL) was mixed with 10 μL of samples (0.1 – 2 μg/μL) and incubated at 37°C for 5 min at 37°C. Then, 200 μL of PT assay reagent (rabbit brain extract and calcium chloride) pre-warmed at 37°C for 10 min was added and the clotting time was recorded by a digital coagulometer ("Laser Sensor" Clotimer, CLOT, São Paulo, SP, Brazil). Plasma alone (only with vehicle) was used as control (absence of anticoagulant activity). Heparin (1 IU/mL) (Cristalia®, Itapira, SP, Brazil) was used as positive control.
Activated partial thromboplastin time (aPPT) test
The action in intrinsic and common pathways was evaluated by aPTT test, as previously described in literature, with a few modifications. The test was carried out using commercial reagent kits (CLOT Bios Diagnostica, São Paulo, SP, Brazil). Plasma (90 μL) was mixed with 10 μL of samples (0.1 – 2 μg/μL) and incubated at 37°C for 5 min at 37°C, before the addition of pre-warmed aPTT reagent (rabbit brain extract and ellagic acid) and incubation at 37°C for 2 min. Pre-warmed (37°C) 25 mM calcium chloride was then added and the clotting time recorded by a digital coagulometer ("Laser Sensor" Clotimer, CLOT, São Paulo, SP, Brazil). Plasma alone (only with vehicle) was used as control (absence of anticoagulant activity). Heparin (1 IU/mL) (Cristalia®, Itapira, SP, Brazil) was used as positive control.
The fibrinolytic activity was determined as previously described in literature, with a few modifications[25, 26]. First, 100 μL of citrated human plasma was mixed with equal volume of 100 mM CaCl2 and incubated at 37°C for 120 min for fibrin clot formation. The plasma fibrin clot was washed 5 times with PBS and then incubated with different concentrations of samples (0.1 – 2 μg/μL) at 37°C for 120 min. 100 μL of 0.0625 M Tris-HCl pH 6.8 containing 10% v/v glycerol, 10% v/v β-mercaptoethanol, 2% w/v SDS and 0.05% w/v bromophenol blue was added, followed by boiling for 5 min. The samples were centrifuged at 800 g for 10 min and the supernatant was then analyzed by 7.5% SDS-PAGE. Plasma fibrin clot alone was used as control, for visualization of the intact fibrin profile. B. jararaca venom was used as positive control for fibrinolytic activity.
The fibrinogenolytic activity was determined as previously described in literature, with a few modifications. Different concentrations of samples (0.1 – 2 μg/μL) were mixed with 50 μg of fibrinogen and then incubated for 180 min at 37°C. 1.5 M Tris-HCl pH 8.8 containing 10% v/v glycerol, 10% v/v β-mercaptoethanol, 2% w/v SDS and 0.05% w/v bromophenol blue was added, followed by boiling for 5 min. The samples were then analyzed by 12% SDS-PAGE. Fibrinogen alone was used as control, for visualization of the intact fibrinogen profile. B. jararaca venom was used as positive control for fibrinogenolytic activity.
The antioxidant activity was evaluated by six in vitro models: total antioxidant capacity, reducing power, copper chelating activity, iron chelating activity, hydroxyl radical scavenging activity and superoxide radical scavenging activity.
Total antioxidant capacity
The assay for total antioxidant capacity was performed using the phosphomolybdenum complex formation method. Tubes containing 100 μg of samples and the reagent solution (0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM ammonium molybdate) were incubated at 95°C for 90 min. Then, the mixture was cooled at room temperature and the absorbance measured at 695 nm against a blank. The total antioxidant activity was interpolated using a standard curve with known concentrations of ascorbic acid and expressed as milligram of ascorbic acid equivalent per gram of extract (AAE).
The reducing power was quantified as described previously, with a few modifications. Samples (0.1 – 2 μg/μL) were added to the reaction mixture (0.2 M phosphate buffer pH 6.6 containing 1% w/v ferricyanide potassium) and incubated at 50°C for 20 min. The reaction was stopped by adding 10% w/v trichloroacetic acid solution. Then, the solution was mixed with water and 0.1% w/v ferric chloride. The absorbances were read at 700 nm. The result was expressed as the percentage of the activity shown by 0.2 μg/μL of ascorbic acid.
Copper chelating activity
The ability to chelate copper ions was assessed using the pyrocatechol violet method. 30 μL of samples (0.1 – 2 μg/μL) were mixed with 200 μL of 50 mM acetate buffer pH 6.0, 6 μL of 4 mM pyrocatechol violet and 100 μL of 50 μg/μL copper II sulfate pentahydrate. The absorbances were read at 632 nm in a microplate reader (Epoch-Biotek®, Winooski, VT, USA). The chelating activity was expressed as the chelation percentage in relation to a blank (absence of sample). The IC50 (concentration that produces 50% of copper ion chelation) was calculated. EDTA was used as positive control.
Iron chelating activity
The ability to chelate iron ions was assessed as previously described in literature, with a few modifications. Samples (0.1 – 2 μg/μL) were added to the reaction mixture containing 2 mM ferrous chloride and 5 mM ferrozine. The mixture was stirred and incubated for 10 min at room temperature. The absorbance was measured at 562 nm. The chelating activity was expressed as the chelation percentage in relation to a blank (absence of sample). The IC50 (concentration that produces 50% of iron ion chelation) was calculated. EDTA was used as positive control.
Hydroxyl radical scavenging activity assay
The scavenging activity against hydroxyl radical was measured based on Fenton’s reaction, as previously described in the literature, with a few modifications. Hydroxyl radicals were generated using 150 mM sodium phosphate buffer pH 7.4 containing 10 mM ferrous sulphate, 10 mM EDTA, 2 mM sodium salicylate and 30% hydrogen peroxide with different concentrations of sample (0.1 – 2 μg/μL). In control tubes, sodium phosphate buffer replaced hydrogen peroxide. The solutions were incubated at 37°C for 60 min, and the presence of hydroxyl radicals was detected by monitoring the absorbance at 510 nm. The scavenging activity was expressed as inhibition percentage (scavenging percentage). The IC50 (concentration that produces 50% of hydroxyl radical scavenging) was calculated. Gallic acid was used as positive control.
Superoxide radical scavenging activity assay
The assay was based on the capacity of the samples to inhibit the photochemical reduction of nitroblue tetrazolium (NBT) in the riboflavin-light-NBT system, as previously described, with a few modifications. The reaction mixture (50 mM phosphate butter pH 7.8, 13 mM methionine, 2 mM riboflavin, 100 mM EDTA and 75 mM NBT) and samples at different concentrations were mixed. After 10 min under illumination with a fluorescent lamp, the production of blue formazan was monitored at 560 nm. Tubes containing only the reaction mixture were maintained in the dark and served as control to reaction. The scavenging activity was expressed as inhibition percentage (scavenging percentage). The IC50 (concentration that produce 50% of superoxide radical scavenging) was calculated. Gallic acid was used as positive control.
As a preliminary study to evaluate the potential toxicity of the plant, in vitro cytotoxicity studies were performed in red blood cell suspension (hemolytic activity) and in human embryonic kidney 293 (HEK-293) cells.
The hemolytic assay was performed as previously described in literature, with a few modifications. Briefly, 5 μL of 20% (v/v) red blood cell (RBC) suspension were incubated at 37°C for 60 min with 500 μL of samples at different concentrations (0.1 – 2 μg/μL). The mixtures were then centrifuged at room temperature for 2 min at 8,600 g and the absorbance of the supernatant was measured at 540 nm with a microplate spectrophotometer (Epoch-Biotek®, Winooski, VT, USA). Water was used as positive control (100% RBC lysis) and PBS as negative control (absence of RBC lysis). The values of treated cells were calculated as a percentage of the positive control.
In vitro cytotoxicity against human embryonic kidney cells (HEK-293)
Human embryonic kidney 293 cells (HEK-293) (ATCC® CRL-1573) were cultured under standard conditions in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with fetal bovine serum (FBS) at a final concentration of 10%. Cells were maintained in cell culture flasks at 37°C in a humidified atmosphere containing 5% CO2 and were collected by treatment with trypsin. Cells (1 × 104 cells per well) were seeded in medium supplemented with FBS (10%) and cultured for 24 h in 96-well microplates to promote adhesion. The following day, the medium was removed and replaced with fresh medium free of FBS. Serum deprivation was used for synchronizing cell cycle. The next day, the medium was replaced with fresh medium with FBS (10%) containing serial dilutions of the samples (3.9 – 1000 μg/mL) previously sterilized in a 0.45 μm membrane. The negative control was exposed to the standard medium supplemented with FBS (10%) without sample. After 24 h, the MTT assay was performed as a marker of cell viability, as previously described in literature. Briefly, medium containing extract was replaced with medium containing 1 μg/μL of MTT and incubated for 4 h at 37°C. After incubation, the supernatant was removed and the purple formazan crystal formed was solubilized in ethanol, stirred for 15 min and the absorbance was measured at 570 nm in a microplate reader (Epoch-Biotek®, Winooski, VT, USA). The absorbance of the negative control (no sample) was considered as 100% cell viability and the values of treated cells were calculated as a percentage of the negative control.
The results were expressed as mean ± SEM with n = 3. One-way ANOVA with Tukey’s post test or Student’s t-test, as well regression analysis were performed using GraphPad Prism version 5.00 for Windows, GraphPad Software, San Diego California USA. p values less than 0.05 were considered significant.
Results and discussion
Antithrombotic drugs are pivotal in the prevention and/or treatment of thrombotic disorders. Secondary metabolites from vegetal origin are a potential source of anticoagulant drugs. Its popular use as well as some interesting studies in literature prompted us to evaluate the anticoagulant activity of J. gossypiifolia.
Teas obtained by decoction of the leaves of J. gossypiifolia are popularly used as an antithrombotic agent and the branches are frequently employed as a "thick blood" agent, a popular claim related to antiplatelet action. Although there is no study in literature about the possible anticoagulant activity of this plant, a previous study showed the potentiality of the juice extracted from the fresh leaves of J. gossypiifolia as an anticoagulant for haematological analyses, with an efficiency comparable to conventional laboratory anticoagulants. Therefore, with the aim of therapeutic purposes, the in vitro anticoagulant action of the aqueous leaf extract of J. gossypiifolia was investigated in the present study.
Yields of extraction and fractionation process of Jatropha gossypiifolia leaves
Crude extract/ fractions
Yield (%), in relation to
The chromatographic analysis of CE and fractions of J. gossypiifolia with specific spray reagents indicated the presence of alkaloids, terpenes and/or steroids, phenolic compounds, flavonoids, tannins and amines.
According to TLCs performed and by comparison with the literature, CH2Cl2 fraction presented green-fluorescent bands when revealed with natural product reagent under UV 365 nm, suggesting the presence of flavonoids, as well brownish bands with Dragendorff’s reagent, suggesting the presence of alkaloids.
In the AcOEt fraction, treatment with ferric chloride revealed several dark bands suggestive of phenolic compounds. The presence of tannins can also be suggested, detectable as pink bands by sulfuric vanillin under heating that revealed as black bands with ferric chloride but are not visualized with natural product reagent. By co-TLC analysis, employing as a mobile phase ethyl acetate: formic acid: water (8:1:1, v/v/v) and revelation with natural product reagent under UV 365 nm, the presence of some bands with Rf (retention factor) and coloration characteristics of the following flavonoids could be observed in AcOEt fraction: isoorientin (Rf = 0.4, dark yellow-orange band), isovitexin (Rf = 0.45, green fluorescent band), orientin (Rf = 0.52, yellow band) and vitexin (Rf = 0.62, green fluorescent band). A band with Rf and coloration characteristics of the flavonoid luteolin (Rf = 0.54, yellow fluorescent band) was also observed by co-TLC in this fraction, employing the mobile phase toluene: ethyl acetate: formic acid (5:5:0.5, v/v/v) and revelation with natural product reagent under UV 365 nm.
The BuOH fraction TLC analysis revealed only flavonoids, since all bands revealed with vanillin were revealed with natural product reagent. By co-TLC, some bands were observed that were similar to those detected in AcOEt fraction: isoorientin, orientin and vitexin.
Content of sugars, phenolic compounds and proteins of crude extract (CE) and residual aqueous fraction (RA) from Jatropha gossypiifolia
Phenolic compounds (%)
20.0 ± 0.3
18.7 ± 1.5
2.4 ± 0.4
15.6 ± 0.6
15.2 ± 1.0
3.7 ± 0.3
Based on these dosages, the presence of phenolic compounds and sugars could be confirmed. In addition, it could be visualized that proteins represent only a low percentage of the crude extract composition.
With the exception of luteolin, the other flavonoids have already been identified in the leaves of J. gossypiifolia[40, 41]. For the genus Jatropha, luteolin was described previously only in the species Jatropha unicostata. Additionally, to the best of our knowledge, there are no phytochemical studies regarding the use of water as solvent for the extraction of J. gossypiifolia constituents. This is important to be noted since popular use occurs more frequently with infusions or decoctions, and thus, little is known about the constitution of this type of extract. Furthermore, more commonly, the studies with J. gossypiifolia presented in the literature use solvents or mixtures of solvents with non polar characteristics, which could contribute to further characterization mainly of non polar compounds such as terpenoids and lignoids. Polar compounds such as flavonoids, tannins and sugars are poorly described in the species so far[12, 17].
Giving continuity to the assessment of the anticoagulant activity of J. gossypiifolia, the four fractions obtained from CE were evaluated by the aPTT and PT test. In relation to PT, no alteration was observed with any of the fractions (results not shown). On the other hand, in the aPTT test, interesting results were obtained, as can be observed in Figure 1. Once again, an action preferentially towards the intrinsic and/or common pathway of coagulation could be suggested for aqueous leaf extract of J. gossypiifolia, since any of the fractions presented prolongation of PT, but some of them prolonged the aPTT. These active fractions in aPTT were the most polar ones: BuOH and RA. The AcOEt presented statistically significant prolongation of aPTT (p < 0.05), however, this anticoagulant activity was not significant from the biological point of view. The BuOH fraction presented anticoagulant activity, but this was weaker than the CE. The RA fraction was the most active, prolonging the aPTT by up to 6 times, being 2 times more active than CE. Based on this, it is possible to conclude that this fraction contains the main compounds responsible for the anticoagulant action observed in the aqueous leaf extract of J. gossypiifolia.
In addition to anticoagulant activity, CE and RA were also tested in relation to their capacity to hydrolyze fibrin and fibrinogen, in view of investigating its potentiality as a thrombolytic agent. However, in both tests employed, no effect was observed (results not shown).
These are interesting results since it show that the anticoagulant activity observed may be due an inhibitory action upon clotting factors, and not only to a simple degradation (proteolytic action) of the proteins involved in the coagulation cascade. Additionally, the fact that only aPTT was prolonged shows that the inhibitory effect is not due to a simple chelation of calcium ions, since if it was true, the PT should be prolonged too, what was not observed. One possible hypothesis for the anticoagulant action observed is the presence of protease inhibitors in CE, especially serine proteases inhibitors, since the coagulation is constituted, basically, of a cascade of proteolytic enzymes. In fact, Félix-Silva et al. showed that the aqueous leaf extract of J. gossypiifolia was able to inhibit several enzymatic and biological activities induced by Bothrops jararaca snake venom, including the inhibition of proteolytic activity of this venom, the inhibition of procoagulant activity upon a solution of crude fibrinogen (which is attributed to serine proteases thrombin-like from snake venom) and in vivo inhibition of the hemorrhagic activity (which is attributed to hemorrhagic metaloproteases from snake venom), showing so that this extract has the ability to inhibit snake venom proteases.
Having in mind the potentiality of CE and, mainly the RA active fraction, as well as considering that the anticoagulant activity associated with antioxidant properties could be beneficial for various cardiovascular diseases, the antioxidant of CE and the RA active fraction were also investigated.
Phenolic compounds are commonly found in both edible and non edible plants, and they have been reported to have multiple biological effects, including antioxidant activity. Extracts rich in phenolics are increasingly of interest to the pharmaceutical and food industry. As discussed before in this paper, we could observe in both CE and RA a great presence of these compounds, which was another factor that prompted us to test the antioxidant activity of these products.
The term "antioxidant" refers to compounds that can prevent the formation of biological substances and chemical oxidation damage induced by reactive species, such as ROS. The formation process of these reactive species occurs through a chain reaction involving three steps (initiation, propagation and termination) wherein the antioxidants act through several mechanisms. Thus, different methods were used to evaluate the effect of CE and RA fraction at the different stages of initiation (e.g. total antioxidant capacity and reducing power), propagation (e.g. chelation of copper and iron ions) and termination (e.g. scavenging of superoxide and hydroxyl radicals).
IC 50 of crude extract (CE) and residual aqueous fraction (RA) from Jatropha gossypiifolia in antioxidant assays
Hydroxyl radical scavenging
0.293 (gallic acid)
Superoxide radical scavenging
0.003 (gallic acid)
The antioxidant activity of extracts from J. gossypiifolia was also evaluated earlier by Kharat et al.. In this work, firstly, the high content of phenols, tannins and flavonoids in the leaves prompted the authors to evaluate the antioxidant activity of the leaves. DPPH free radical, ferric thiocyanate and nitric oxide scavenging methods were used to analyze the in vitro antioxidant activity of methanol, ethyl acetate and aqueous extracts, demonstrating positive results. The authors attributed the free radical scavenging activity to the presence of flavonoids. On the other hand, a study showed that different extracts (petrol ether, chloroform, ethyl acetate and n-butanol) from whole plant of J. gossypiifolia had only partial antioxidant activity in DPPH scavenging, total antioxidant capacity and lipid peroxidation tests. From these extracts, the ethyl acetate was the most active, which correlated positively with its higher content of phenolic compounds in comparison with the other extracts.
Considering that Jatropha species are known to be toxic and considering previous studies that showed that ethanol extracts from J. gossypiifolia aerial parts exhibited noticeable toxicity[12, 49], in vitro cytotoxicity studies were performed as a preliminary method to evaluate the potential toxicity of CE and the active fraction RA.
The potential hemolytic activity of CE and RA was investigated by measuring the lysis of a 20% (v/v) human red blood cell (RBC) suspension in a spectrophotometric lysis assay. CE and RA were tested at different concentrations (up to 2 μg/μL) and no significant red blood cell lysis was observed (results not shown). Red blood cells hemolysis is characterized by the breakdown of the red blood cell membrane leading to the release of hemoglobin into the surrounding plasma. This deleterious event can be caused by a large number of conditions and can lead to anemia and hypoxia. The osmotic fragility of the red blood cell is classically used as an in vitro assay to evaluate the effects of chemicals on cell membrane[35, 50].
The in vitro cytotoxicity of CE and RA was evaluated in cell culture against human kidney epithelial cell line (HEK-293 cells) by MTT assay, which measures indirectly the cellular viability by quantification of the amount of blue formazan crystals, which are the product from the cleavage of MTT by cells presenting active mitochondria. The results showed that at any concentration tested (up to 1 μg/μL) CE and RA were not cytotoxic, with a viability percentage similar to the control cells (treated only with medium in absence of sample) (results not shown).
The results suggest that even with the concentration of the bioactive compounds in the RA fraction, there was no increase in the toxicity of this fraction in relation to CE. It is important to note that both RBC and HEK-293 are human cells, which can reinforce the absence of cytotoxicity by CE and RA. These results suggest that the aqueous extract of the leaves, compared to the ethanol extract of the aerial parts tested by Mariz et al. may be less toxic possibly due to an eventual difference in chemical composition that may have occurred, taking into account both the different plant parts and extractor solvent used for the different preparation of the extracts. In fact, a study investigating the acute oral toxicity of an aqueous leaf extract of J. gossypiifolia showed no sign of toxicity in rats in doses up to 2,000 mg/kg.
In conclusion, the presented results showed that J. gossypiifolia leaves, especially RA fraction, have significant beneficial effects as an anticoagulant and antioxidant agent. In addition, the absence of in vitro cytotoxicity against human cells could reinforce its therapeutic potential. Thus, this study shows the potential of this plant as a new source of bioactive molecules for therapeutic purposes.
The results shown in this work demonstrate that the aqueous leaf extract of the vegetal species Jatropha gossypiifolia has significant anticoagulant activity. Using a bioguided fractionation assay, it was possible to conclude that the fraction responsible for the activity in the crude extract was the residual aqueous fraction. In addition to the anticoagulant activity, this fraction also proved to be a good source of antioxidant compounds. Since compounds with anticoagulant and antioxidant can be used in current medicine for treatment of various cardiovascular diseases, we suggest that based in our results, the aqueous leaf extract of J. gossypiifolia, specially its residual aqueous fraction, shows promising potential as a future therapeutic agent. In addition, the absence of in vitro cytotoxicity against human cells could reinforce its potential. Thus, the results presented here could give scientific evidence, at least partially, for the popular use of this plant in complementary and alternative medicine and show its potential as a new source of bioactive molecules for therapeutic purposes.
MFFP and HAOR are CNPq fellowship-honored researchers.
Ethyl acetate fraction of J. gossypiifolia crude extract
Activated partial thromboplastin time
n-butanol fraction of J. gossypiifolia crude extract
J. gossypiifolia crude extract
- CH2Cl2 :
Dichloromethane fraction of J. gossypiifolia crude extract
Ethylenediamine tetraacetic acid
Human embryonic kidney 293 cells
Phosphate buffered saline
Residual aqueous fraction of J. gossypiifolica crude extract
Red blood cell suspension
Reactive oxygen species
Thin layer chromatography.
The authors thank CAPES, CNPq, BNB and FAPERN for financial support. J. Félix-Silva and B. Cabral give thanks to CAPES for the PhD and Master Scholarship, respectively. T. Souza thanks CNPq for the Scholarship in Scientific Initiation. R.B.G. Camara gives thanks to CAPES for PhD Scholarship. The authors thank Andrew Alastair Cumming for editing this manuscript for the English revision. The authors also thank the students Yamara Arruda Silva de Menezes and Argos Henrique Albuquerque da Costa for technical assistance.
- Calixto JB: Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res. 2000, 33: 179-189. 10.1590/S0100-879X2000000200004.View ArticlePubMedGoogle Scholar
- Newman DJ, Cragg GM: Natural products as sources of new drugs over the 30 years from 1981 to 2010. J N Prod. 2012, 75: 311-335. 10.1021/np200906s.View ArticleGoogle Scholar
- Moll S, Roberts HR: Overview of anticoagulant drugs for the future. Semin Hematol. 2002, 39: 145-157. 10.1053/shem.2002.34087.View ArticlePubMedGoogle Scholar
- Lapikova ES, Drozd NN, Tolstenkov AS, Makarov VA, Zvyagintseva TN, Shevchenko NM, Bakunina IU, Besednova NN, Kuznetsova TA: Inhibition of thrombin and factor Xa by Fucus evanescens fucoidan and its modified analogs. Bull Exp Biol Med. 2008, 146: 328-333. 10.1007/s10517-008-0267-3.View ArticlePubMedGoogle Scholar
- Chaves DSA, Costa SS, Almeida AP, Frattani F, Assafim M, Zingali RB: Metabólitos secundários de origem vegetal: uma fonte potencial de fármacos antitrombóticos. Quim Nova. 2010, 33: 172-180. 10.1590/S0100-40422010000100030.View ArticleGoogle Scholar
- Chen K, Keaney JF: Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep. 2012, 14: 476-483. 10.1007/s11883-012-0266-8.View ArticlePubMedGoogle Scholar
- Uttara B, Singh AV, Zamboni P, Mahajan RT: Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009, 7: 65-74. 10.2174/157015909787602823.View ArticlePubMedPubMed CentralGoogle Scholar
- Nascimento AKL, Melo-Silveira RF, Dantas-Santos N, Fernandes JM, Zucolotto SM, Rocha HAO, Scortecci KC: Antioxidant and antiproliferative activities of leaf extracts from Plukenetia volubilis Linneo (Euphorbiaceae). Evid Based Complement Alternat Med. 2013, 2013: 1-10.View ArticleGoogle Scholar
- Kähkönen MP, Hopia AI, Vuorela HJ, Rauha JP, Pihlaja K, Kujala TS, Heinonen M: Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem J. 1999, 47: 3954-3962. 10.1021/jf990146l.View ArticleGoogle Scholar
- Chumark P, Khunawat P, Sanvarinda Y, Phornchirasilp S, Morales NP, Phivthong-ngam L, Ratanachamnong P, Srisawat S, Pongrapeeporn KS: The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves. J Ethnopharmacol. 2008, 116: 439-446. 10.1016/j.jep.2007.12.010.View ArticlePubMedGoogle Scholar
- Wang W, Lee Y, Lee CH: Review: the physiological and computational approaches for atherosclerosis treatment. Int J Cardiol. 2013, 167: 1664-1676. 10.1016/j.ijcard.2012.09.195.View ArticlePubMedGoogle Scholar
- Mariz SR, Borges ACR, Melo-Diniz MFF, Medeiros IA: Possibilidades terapêuticas e riscos toxicológicos de Jatropha gossypiifolia L.: uma revisão narrativa. Rev Bras Plantas Med. 2010, 12: 346-357. 10.1590/S1516-05722010000300013.View ArticleGoogle Scholar
- Albuquerque UP, Medeiros PM, Almeida ALS, Monteiro JM, Freitas Lins Neto EM, Melo JG, Santos JP: Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: a quantitative approach. J Ethnopharmacol. 2007, 114: 325-354. 10.1016/j.jep.2007.08.017.View ArticlePubMedGoogle Scholar
- Di Stasi LC, Hiruma-Lima CH: Plantas medicinais na Amazônia e na Mata Atlântica. 2002, São Paulo: UNESP, 2Google Scholar
- Félix-Silva J, Giordani RB, Silva AA, Zucolotto SM, Fernandes-Pedrosa MF: Jatropha gossypiifolia L. (Euphorbiaceae): a review of traditional uses, phytochemistry, pharmacology, and toxicology of this medicinal plant. Evid Based Complement Alternat Med. 2014, 2014: 1-32.View ArticleGoogle Scholar
- Fitoterapia: plantas de interesse ao SUS. [http://www.unifalmg.edu.br/hpmed/files/RENISUS.pdf],
- Zhang XP, Zhang ML, Su XH, Huo CH, Gu YC, Shi QW: Chemical constituents of the plants from genus Jatropha. Chem Biodivers. 2009, 6: 2166-2183. 10.1002/cbdv.200700461.View ArticlePubMedGoogle Scholar
- Félix-Silva J, Souza T, Menezes YAS, Cabral B, Camara RBG, Silva-Junior AA, Rocha HAO, Rebecchi IMM, Zucolotto SM, Fernandes-Pedrosa MF: Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom. PLoS One. 2014, 9: e104952-10.1371/journal.pone.0104952.View ArticlePubMedPubMed CentralGoogle Scholar
- Félix-Silva J, Gomes JAS, Barbosa LMQ, Pinheiro ITMG, Soares LAL, Silva-Júnior AA, Zucolotto SM, Fernandes-Pedrosa MF: Systemic and local anti-inflammatory activity of aqueous leaf extract from Jatropha gossypiifolia L. (Euphorbiaceae). Int J Pharm Pharm Sci. 2014, 6: 142-145.Google Scholar
- Wagner H, Bladt S: Plant Drug Analysis: a Thin Layer Chromatography Atlas. 2001, Germany: Springer, 2Google Scholar
- Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F: Colorimetric method for determination of sugars and related substances. Anal Chem. 1956, 28: 350-356. 10.1021/ac60111a017.View ArticleGoogle Scholar
- Singleton VL, Orthofer R, Lamuela-Raventós RM: Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1998, 299: 152-178.View ArticleGoogle Scholar
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.View ArticlePubMedGoogle Scholar
- Mao W, Li H, Li Y, Zhang H, Qi X, Sun H, Chen Y, Guo S: Chemical characteristic and anticoagulant activity of the sulfated polysaccharide isolated from Monostroma latissimum (Chlorophyta). Int J Biol Macromol. 2009, 44: 70-74. 10.1016/j.ijbiomac.2008.10.003.View ArticlePubMedGoogle Scholar
- Menezes YAS, Félix-Silva J, Silva-Júnior AA, Rebecchi IMM, Oliveira AS, Uchoa AF, Fernandes-Pedrosa MF: Protein-rich fraction of Cnidoscolus urens (L.) Arthur leaves: enzymatic characterization and procoagulant and fibrinogenonlytic activities. Molecules. 2014, 19: 3552-3569. 10.3390/molecules19033552.View ArticlePubMedGoogle Scholar
- Rajesh R, Raghavendra Gowda CD, Nataraju A, Dhananjaya BL, Kemparaju K, Vishwanath BS: Procoagulant activity of Calotropis gigantea latex associated with fibrin(ogen)olytic activity. Toxicon. 2005, 46: 84-92. 10.1016/j.toxicon.2005.03.012.View ArticlePubMedGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0.View ArticlePubMedGoogle Scholar
- Maruyama M, Sugiki M, Yoshida E, Mihara H, Nakajima N: Purification and characterization of two fibrinolytic enzymes from Bothrops jararaca (jararaca) venom. Toxicon. 1992, 30: 853-864. 10.1016/0041-0101(92)90383-G.View ArticlePubMedGoogle Scholar
- Rodrigues VM, Soares AM, Guerra-Sá R, Rodrigues V, Fontes MRM, Giglio JR: Structural and functional characterization of neuwiedase, a nonhemorrhagic fibrin(ogen)olytic metalloprotease from Bothrops neuwiedi snake venom. Arch Biochem Biophys. 2000, 381: 213-224. 10.1006/abbi.2000.1958.View ArticlePubMedGoogle Scholar
- Pietro P, Pineda M, Aguilar M: Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem. 1999, 269: 337-341. 10.1006/abio.1999.4019.View ArticleGoogle Scholar
- Wang J, Zhang Q, Zhang Z, Li Z: Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica. Int J Biol Macromol. 2008, 42: 127-132. 10.1016/j.ijbiomac.2007.10.003.View ArticlePubMedGoogle Scholar
- Anton A: Colorimetric estimation of aluminum with pyrocatechol violet. Anal Chem. 1960, 32: 725-726. 10.1021/ac60162a052.View ArticleGoogle Scholar
- Smirnoff N, Cumbes QJ: Hydroxyl radical scavenging activity of compatible solutes. Phytochemistry. 1989, 28: 1057-1060. 10.1016/0031-9422(89)80182-7.View ArticleGoogle Scholar
- Dasgupta N, De B: Antioxidant activity of Piper betle L. leaf extract in vitro. Food Chem. 2004, 88: 219-224. 10.1016/j.foodchem.2004.01.036.View ArticleGoogle Scholar
- Robert S, Baccelli C, Devel P, Dogné J-M, Quetin-Leclercq J: Effects of leaf extracts from Croton zambesicus Müell. Arg. on hemostasis. J Ethnopharmacol. 2010, 128: 641-648. 10.1016/j.jep.2010.02.007.View ArticlePubMedGoogle Scholar
- Mossmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.View ArticleGoogle Scholar
- Cartaxo SL, De Almeida Souza MM, De Albuquerque UP: Medicinal plants with bioprospecting potential used in semi-arid northeastern Brazil. J Ethnopharmacol. 2010, 131: 326-342. 10.1016/j.jep.2010.07.003.View ArticlePubMedGoogle Scholar
- Coelho-Ferreira M: Medicinal knowledge and plant utilization in an Amazonian coastal community of Marudá, Pará State (Brazil). J Ethnopharmacol. 2009, 126: 159-175. 10.1016/j.jep.2009.07.016.View ArticlePubMedGoogle Scholar
- Oduola T, Avwioro OG, Ayanniyi TB: Suitability of the leaf extract of Jatropha gossypifolia as an anticoagulant for biochemical and haematological analyses. Afr J Biotechnol. 2005, 4: 679-681. 10.5897/AJB2005.000-3125.View ArticleGoogle Scholar
- Pilon AC, Carneiro RL, Carnevale Neto F, Bolzani VS, Castro-Gamboa I: Interval multivariate curve resolution in the dereplication of HPLC-DAD data from Jatropha gossypifolia. Phytochem Anal. 2013, 24: 401-406. 10.1002/pca.2423.View ArticlePubMedGoogle Scholar
- Subramanian SS, Nagarajan S, Sulochana N: Flavonoids of the leaves of Jatropha gossypiifolia. Phytochemistry. 1971, 10: 1690-1690. 10.1016/0031-9422(71)85055-0.View ArticleGoogle Scholar
- Franke K, Nasher AK, Schmidt J: Constituents of Jatropha unicostata. Biochem Sys Ecol. 2004, 32: 219-220. 10.1016/S0305-1978(03)00140-6.View ArticleGoogle Scholar
- Melo KRT, Camara RBC, Queiroz MF, Vidal AAJ, Lima CRM, Melo-Silveira RF, Almeida-Lima J, Rocha HAO: Evaluation of sulfated polysaccharides from the brown seaweed Dictyopteris justii as antioxidant agents and as inhibitors of the formation of calcium oxalate crystals. Molecules. 2013, 18: 14543-14563. 10.3390/molecules181214543.View ArticlePubMedGoogle Scholar
- McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985, 312: 159-163. 10.1056/NEJM198501173120305.View ArticlePubMedGoogle Scholar
- Svingen BA, Buege JA, O'neal FO, Aust SD: The mechanism of NADPH-dependent lipid peroxidation: the propagation of lipid peroxidation. J Biol Chem. 1979, 254: 5892-5899.PubMedGoogle Scholar
- Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007, 39: 44-84. 10.1016/j.biocel.2006.07.001.View ArticlePubMedGoogle Scholar
- Kharat AR, Dolui AK, Das S: Free radical scavenging potential of Jatropha gossypifolia. Asian J Chem. 2011, 23: 799-801.Google Scholar
- Shahwar D, Shafiqur R, Ahmad N, Ullah S, Raza MA: Antioxidant activities of the selected plants from the family Euphorbiaceae, Lauraceae, Malvaceae and Balsaminaceae. Afr J Biotechnol. 2010, 9: 1086-1096.View ArticleGoogle Scholar
- Devappa RK, Makkar HPS, Becker K: Jatropha toxicity - a review. J Toxicol Environ Health B Crit Rev. 2010, 13: 476-507. 10.1080/10937404.2010.499736.View ArticlePubMedGoogle Scholar
- Souza-Lima MCJ, Soto-Blanco B: Poisoning in goats by Aspidosperma pyrifolium Mart.: biological and cytotoxic effects. Toxicon. 2010, 55: 320-324. 10.1016/j.toxicon.2009.08.004.View ArticlePubMedGoogle Scholar
- Mariz SR, Cerqueira GS, Araújo WC, Dantas JG, Ramalho JA, Palomaro TV, Duarte JC, Dos Santos HB, Olveira K, De Araújo MST, Diniz MFFM, de Medeiros IA: Chronic toxicologic study of the ethanolic extract of the aerial parts of Jatropha gossypiifolia in rats. Rev Bras Farmacogn. 2012, 22: 663-668. 10.1590/S0102-695X2012005000024.View ArticleGoogle Scholar
- Nagaharika Y, Kalyani V, Rasheed S, Karthikeyan R: Anti-inflammatory activity of leaves of Jatropha gossypifolia L. by HRBC membrane stabilization method. JAD. 2013, 2: 156-158.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/405/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.